50 years of Uof Mississippi research. Experienced management with Murphy and new scientific board additions. Avthar Dillon of Emerald. Global patents. Human trials early next year. My FDA tracked cannabinoid stock mania theory.
Nemus has the potential to go to $1-2 pretty easily.
Something happened - which unleashed the power of our imagination...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.